Category Archives: Health Care

Sedentary lifestyle cause for increase in knee and hip replacement surgery in the Arab world

More than 40 international and regional joint reconstruction experts at ICJR-ME in Dubai.

|

In Obama Budget, ‘Small’ Business Gets Bigger

WASHINGTON (MedPage Today) — The Obama administration’s budget proposal allows more employers to qualify for a tax credit to offset the costs of providing health insurance to their workers.

|

Congress Passes 10-Month SGR Fix

WASHINGTON (MedPage Today) — Congress has passed a compromise bill that would delay the impending 27% cut in Medicare pay rates for 10 months.

|

CardioGen Gets Boxed Warning

(MedPage Today) — CardioGen-82, a generator that produces the PET imaging agent rubidium-82, can return to market, says the FDA, but it must carry a new boxed warning.

|

FDA Reviewers Divided on Second Round for Diet Drug

WASHINGTON (MedPage Today) — The weight-loss pill phentermine/topiramate (Qnexa) helps overweight and obese patients lose weight, but may also increase the risk for cleft palates in babies born to mothers who took the pill while pregnant, FDA reviewers said.

|

EHR Adoption Way Up in Hospitals

WASHINGTON (MedPage Today) — The number of hospitals using health information technology has more than doubled in the past two years, Health and Human Services (HHS) Secretary Kathleen Sebelius announced.

|

Mifepristone Wins Nod for Use in Cushing’s Disease

(MedPage Today) — Mifepristone, best known as the “abortion pill” once called RU-486, has been approved for treating hyperglycemia associated with endogenous Cushing’s disease, the FDA said.

|

Drug-Eluting Stent Approved for Diabetics

(MedPage Today) — The FDA has approved the Resolute Integrity drug-eluting stent, the first such stent to carry an indication for use in diabetics with coronary artery disease, according to a statement from the manufacturer.

|

Washington Week: SGR Fix Passed

WASHINGTON –Congress passed a bill to delay a scheduled 27% cut in Medicare payments by 10 months, and the president released his 2013 budget proposal, which requests a slight increase for health programs.

|

EU and US Regulatory Update – Tykerb/Tyverb® (lapatinib)

GlaxoSmithKline announced today that it has submitted regulatory applications in Europe and the US related to Tykerb/ Tyverb (lapatinib) and its use in combination with trastuzumab to treat patients with HER2 (ErbB2)-positive metastatic breast cancer.

|